Key Points
- Insider sale: Director J. Robert Kerrey sold 12,010 Tenet Healthcare shares for approximately $3.17 million at an average price of $263.72, reducing his direct holdings by 71.47% to 4,794 shares.
- Strong financial performance: Tenet reported quarterly EPS of $6.12, exceeding estimates of $4.26, while revenue reached $6.04 billion and rose 6.8% year over year. The company issued fiscal 2026 EPS guidance of $20.30–$21.69.
- Positive analyst sentiment: Analysts maintain a consensus “Buy” rating with an average price target of $275.53, while institutional investors own 95.44% of the company’s stock.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director J. Robert Kerrey sold 12,010 shares of the company's stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $263.72, for a total value of $3,167,277.20. Following the transaction, the director directly owned 4,794 shares of the company's stock, valued at approximately $1,264,273.68. This trade represents a 71.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Tenet Healthcare Trading Up 1.8%
Tenet Healthcare stock opened at $265.56 on Thursday. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The firm has a 50-day moving average of $248.41 and a 200-day moving average of $212.79. The company has a market cap of $21.38 billion, a price-to-earnings ratio of 10.24, a P/E/G ratio of 0.99 and a beta of 1.23. Tenet Healthcare Corporation has a one year low of $157.58 and a one year high of $283.05.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts' consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts expect that Tenet Healthcare Corporation will post 21.04 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
THC has been the subject of a number of recent research reports. Piper Sandler set a $308.00 price objective on shares of Tenet Healthcare in a report on Monday, July 27th. Raymond James Financial reaffirmed an "outperform" rating and set a $285.00 price target on shares of Tenet Healthcare in a report on Friday, August 14th. Stephens reaffirmed an "overweight" rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. The Goldman Sachs Group reissued a "buy" rating and issued a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Zacks Research raised Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $275.53.
Get Our Latest Analysis on THC
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Elyxium Wealth LLC purchased a new position in Tenet Healthcare during the 4th quarter worth $29,000. Trust Co. of Vermont bought a new stake in Tenet Healthcare in the 2nd quarter worth about $37,000. OP Asset Management Ltd bought a new position in shares of Tenet Healthcare during the 1st quarter worth approximately $49,000. Compass Financial Management LLC purchased a new position in shares of Tenet Healthcare in the 2nd quarter worth approximately $57,000. Finally, William B. Walkup & Associates Inc. increased its position in shares of Tenet Healthcare by 88.7% during the fourth quarter. William B. Walkup & Associates Inc. now owns 302 shares of the company's stock valued at $60,000 after acquiring an additional 142 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.
Key Stories Impacting Tenet Healthcare
Here are the key news stories impacting Tenet Healthcare this week:
- Positive Sentiment: Strong analyst and quantitative support: Zacks highlighted Tenet among hospital operators benefiting from steady healthcare demand and improved efficiency. THC was also added to Zacks’ Rank #1 “Strong Buy” lists for both growth and value stocks, reinforcing the view that its earnings outlook and valuation remain attractive. 3 Hospital Stocks Riding Strong Demand and Improved Efficiency Best Growth Stocks to Buy for September 16th Best Value Stocks to Buy for September 16th
- Positive Sentiment: Potential undervaluation and earnings momentum: Zacks’ latest analysis points to favorable value, growth and momentum characteristics. That view is supported by Tenet’s latest quarterly results, which exceeded earnings and revenue estimates, with revenue increasing year over year. Are Investors Undervaluing Tenet Healthcare
- Positive Sentiment: Ambulatory strategy remains a strength: Coverage of United Surgical Partners International, Tenet’s ambulatory surgery platform, keeps attention on outpatient care, an area that can support more efficient growth and portfolio optimization. Tenet’s full-year 2026 EPS guidance and predominantly positive analyst ratings also support the bullish case. 5 Things to Know About United Surgical Partners International
- Neutral Sentiment: Restructuring creates mixed implications: Tenet’s $2.7 billion Conifer breakup is reportedly leading to 1,037 job cuts. The separation could streamline operations and sharpen strategic focus, but the near-term workforce reduction highlights execution and restructuring risks. Tenet’s $2.7B Conifer Breakup Triggers 1,037 Job Cuts
- Negative Sentiment: Director stock sale: Director Richard Mark sold 10,000 THC shares for approximately $2.6 million, reducing his position by 28.47%. The transaction is relatively small compared with Tenet’s market value but may weigh modestly on sentiment because it represents insider selling. Richard Mark Sells 10,000 Shares of Tenet Healthcare
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women's health and other inpatient and outpatient treatments.
Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
